CLASS II ONGOING Device recall · Reported 18 Jan 2023 · FDA Enforcement Report

Philips Fetal Spiral Electrode-intended recalled

Philips North America is recalling Philips Fetal Spiral Electrode-intended for patients requiring fetal heart rate, distributed nationwide in the US. The recall was initiated on 21 Nov 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: (01)20884838007431. All devices shipped to and received by the customer from Philips between May 2020 until end Nov 2022
Quantity recalled69,679 cases (1,741,975 units)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0908-2023
FDA event ID
91220
Recalling firm
Philips North America, Cambridge, MA
Classification
Class II
Status
Ongoing
Recall initiated
21 Nov 2022
FDA classified
6 Jan 2023
Reported
18 Jan 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Patient Monitors

Timeline

21 Nov 2022Recall initiated by company
6 Jan 2023Classified by FDA+46 days
18 Jan 2023Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Fetal Spiral Electrode (FSE) spiral tip of the FSE breaking off during use and requiring surgical intervention to remove the broken tip from the neonate patient. Philips has decided to discontinue the distribution of this product.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Philips Fetal Spiral Electrode-intended for patients requiring fetal heart rate monitoring during labor. PN: 989803137631

Where it was distributed

Worldwide distribution - US Nationwide and the countries of Australia, Austria, Bahrain, Belgium, Canada, China, Croatia, Cura¿ao, Czechia, Denmark, Faroe Islands, Finland, France, Germany, Hong Kong, Iceland, India, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kuwait, Latvia, Luxembourg, Malaysia, Netherlands, New Zealand, Norway, Oman, Portugal, Puerto Rico, Qatar, Russia, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Tanzania, United Republic Trinidad and Tabago, United Arab Emerates, United Kingdom.

Nationwide Puerto Rico

Questions about this recall

Is Philips Fetal Spiral Electrode-intended for patients requiring fetal heart rate recalled?

Yes. Philips North America recalled Philips Fetal Spiral Electrode-intended for patients requiring fetal heart rate on 21 Nov 2022. The recall is Class II and its status is Ongoing. Recall number Z-0908-2023.

Why was it recalled?

Fetal Spiral Electrode (FSE) spiral tip of the FSE breaking off during use and requiring surgical intervention to remove the broken tip from the neonate patient. Philips has decided to discontinue the distribution of this product.

Which lots are affected?

UDI: (01)20884838007431. All devices shipped to and received by the customer from Philips between May 2020 until end Nov 2022

Where was it sold?

Worldwide distribution - US Nationwide and the countries of Australia, Austria, Bahrain, Belgium, Canada, China, Croatia, Cura¿ao, Czechia, Denmark, Faroe Islands, Finland, France, Germany, Hong Kong, Iceland, India, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kuwait, Latvia, Luxembourg, Malaysia, Netherlands, New Zealand, Norway, Oman, Portugal, Puerto Rico, Qatar, Russia, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Tanzania, United Republic Trinidad and Tabago, United Arab Emerates, United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Philips North America

All 531

Other Patient Monitors recalls

All 1,013